Cargando…

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine

PURPOSE: The purpose of this study was to assess the preventive effect of cilostazol on in-stent restenosis in patients after superficial femoral artery (SFA) stent placement. MATERIALS AND METHODS: Of 28 patients with peripheral arterial disease, who had successfully undergone stent implantation, 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikushima, Ichiro, Yonenaga, Kazuchika, Iwakiri, Hironao, Nagoshi, Hideki, Kumagai, Haruhito, Yamashita, Yasuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417878/ https://www.ncbi.nlm.nih.gov/pubmed/22915934 http://dx.doi.org/10.2147/MDER.S21629

Ejemplares similares

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
por: Tobita, Kazuki, et al.
Publicado: (2023)

Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
por: Vu, Michael H., et al.
Publicado: (2022)

Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trials
por: HU, FENG-HUAN, et al.
Publicado: (2013)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency()
por: Marples, Rory, et al.
Publicado: (2021)

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
por: Berger, Peter B
Publicado: (2000)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study
por: Miura, Takashi, et al.
Publicado: (2022)

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
por: Chung, Jong-Won, et al.
Publicado: (2019)

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Tong, Zhu, et al.
Publicado: (2020)

Atrial Fibrillation is Associated with Femoropopliteal Totally Occlusive In-Stent Restenosis: A Single-Center, Retrospective, Observational Study
por: Honda, Yohsuke, et al.
Publicado: (2021)

Possible effect of direct oral anti-coagulant for preventing long stenting lesion from in-stent restenosis in femoropopliteal segment: Case report with angioscopy findings
por: Tsuchiya, Taketsugu, et al.
Publicado: (2020)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation
por: Kato, Yuta, et al.
Publicado: (2017)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Lumivascular Optical Coherence Tomography–Guided Atherectomy in Recurrent Femoropopliteal Occlusive Diseases Associated with In-Stent Restenosis: Case-Series Report
por: Chan, Yiu Che, et al.
Publicado: (2020)

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis
por: Cao, Shaobo, et al.
Publicado: (2021)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
por: Ryu, Jae-Chan, et al.
Publicado: (2023)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Trans-stent graft thrombectomy for the treatment of long stent graft thrombosis in the femoropopliteal artery
por: Ozawa, Hirotsugu, et al.
Publicado: (2021)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

Inflammation and In-Stent Restenosis: The Role of Serum Markers and Stent Characteristics in Carotid Artery Stenting
por: Wasser, Katrin, et al.
Publicado: (2011)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
por: Li, Liqiang, et al.
Publicado: (2022)

Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018)

Diagnostic value of intraluminal stent enhancement in estimating coronary in-stent restenosis
por: Nogourani, Mehdi Karami, et al.
Publicado: (2020)

Effects of a Matrix Metalloproteinase Inhibitor-Eluting Stent on In-Stent Restenosis
por: Song, Jian-bo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u26aphpibjfe1odi5nid7793ga